Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
"Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly's SURPASS program" (Press release)
PMID: 41509291 bioRxiv Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity
Mentally I've also felt very good
What is included MEDVi program pricing covers the following: Telehealth consultation with a licensed medical provider who reviews your health assessment and creates a personalized treatment plan Prescription medication shipped in temperature-controlled packaging directly to your door Free shipping on all medication deliveries 24/7 messaging support with your assigned care team for questions about dosing, side effects, or treatment adjustments Lab testing through Quest Diagnostics when medically indicated, at no additional cost Dosage adjustments coordinated through provider messaging as your treatment progresses Metabolic reporting that tracks relevant health markers over time The 24/7 messaging support is a genuine differentiator
The funds will be deducted automatically from the members appropriate HRA, HSA, or FSA account
It should be administered under medical supervision
